INSIGHTS ON ENTERPRISE SOLUTIONS

• ESACT 2026: Reducing Variability With Animal‑Origin‑Free Peptones

  Explore how data‑driven collaboration and animal‑origin‑free media strategies can reduce variability, improve cell culture performance, and support consistent, cost‑effective bioprocessing at scale.

• Managing CMC Risk For Complex Peptide And Nucleic Acid Therapeutics

  At TIDES USA 2026, experts discuss how formulation science, stability strategies, and advanced analytics help reduce CMC risk and enable confident development of peptide and nucleic acid therapeutics.

• Using Client Centricity As Fuel For Innovative Biologics Development And Manufacturing Solutions

  Complex biologics require flexible development, advanced analytics, and quality by design. Learn how collaborative bioprocessing reduces risk, enables efficient scale‑up, and supports clinical success.

• Providing Solutions In Titer, Host Cell Protein, And Scalability

  By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, see how we were able to enable a highly data-driven approach to clone selection and process optimization.

• Quality By Design Understanding And Securing Virus Clearance

  4/22/2026

  Data-driven virus clearance improves risk assessment, process insight, and study design. Learn how Quality by Design cuts late-stage risk while strengthening regulatory confidence and viral safety.

• Tech Transfer Roundtable: Real World Lessons From Rentschler Biopharma's Experts

  4/22/2026

  Real‑world lessons for planning and executing tech transfers, with practical insights on early alignment, process readiness, risk reduction, and cross‑functional coordination for smoother scale‑up.

• How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency?

  4/21/2026

  Manufacturing flexibility is now a competitive differentiator. Here's how single-use technologies are reshaping bioprocessing facility design, scalability, and sustainability strategy.

• 3 Innovations For Reducing Risk In Continuous Downstream Bioprocessing

  4/21/2026

  Batch-to-continuous transitions in downstream bioprocessing carry real risks. Here's how advanced analytics, smarter buffer strategies, and single-use systems are changing that calculus.